Shanghai, China

Hongshun Yuan

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Selection Bioscience LLC. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongshun Yuan. Retrieved from https://idiyas.com/inventor/hongshun-yuan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hongshun Yuan

Introduction

Hongshun Yuan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit poly(ADP-ribose) polymerase (PARP). His work is crucial for advancing treatments for various diseases, including cancers and inflammatory conditions.

Latest Patents

Hongshun Yuan holds a patent for a compound described as a poly(ADP-ribose) polymerase inhibitor. The patent outlines a preparation method and its use, detailing a compound represented by a general formula. This compound exhibits strong PARP inhibitory activity, making it a potential therapeutic agent for diseases associated with PARP.

Career Highlights

Throughout his career, Hongshun Yuan has worked with several prominent companies, including Selection Bioscience LLC and Zhang Fuyao. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovation and research.

Collaborations

Some of his notable coworkers include Fuyao Zhang and Xiaoming Shen. Their collaborative efforts have contributed to the advancement of research in the field of PARP inhibitors.

Conclusion

Hongshun Yuan's innovative work in developing PARP inhibitors showcases his commitment to improving therapeutic options for serious health conditions. His contributions to the pharmaceutical industry are significant and continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…